Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception | Journal of Pharmacology and Experimental Therapeutics

This is a PDF-only article. The first page of the PDF of this article appears below.

PDF extract preview

In this issue

Related Articles

Cited By...

More in this TOC Section

Pharmacological Characterization of Synthetic Cannabinoids
The Nurr1 ligand,1,1-bis(3'-indolyl)-1-(p-chlorophenyl)methane, modulates glial reactivity and is neuroprotective in MPTP-induced parkinsonism
Pharmacological characterizations of H05, a novel potent serotonin and noradrenaline reuptake inhibitor with moderate 5-HT2A antagonist activity for anti-depression

Show more Neuropharmacology

Similar Articles